197 related articles for article (PubMed ID: 34555271)
21. Detection of mutations in folp1, rpoB and gyrA genes of M. leprae by PCR- direct sequencing--a rapid tool for screening drug resistance in leprosy.
Sekar B; Arunagiri K; Kumar BN; Narayanan S; Menaka K; Oommen PK
Lepr Rev; 2011 Mar; 82(1):36-45. PubMed ID: 21644470
[TBL] [Abstract][Full Text] [Related]
22. Functional characterization of a small heat shock protein from Mycobacterium leprae.
Lini N; Rehna EA; Shiburaj S; Maheshwari JJ; Shankernarayan NP; Dharmalingam K
BMC Microbiol; 2008 Nov; 8():208. PubMed ID: 19040732
[TBL] [Abstract][Full Text] [Related]
23. Structural Implications of Mutations Conferring Rifampin Resistance in Mycobacterium leprae.
Vedithi SC; Malhotra S; Das M; Daniel S; Kishore N; George A; Arumugam S; Rajan L; Ebenezer M; Ascher DB; Arnold E; Blundell TL
Sci Rep; 2018 Mar; 8(1):5016. PubMed ID: 29567948
[TBL] [Abstract][Full Text] [Related]
24. Investigating drug resistance of Mycobacterium leprae in the Comoros: an observational deep-sequencing study.
Marijke Braet S; Jouet A; Aubry A; Van Dyck-Lippens M; Lenoir E; Assoumani Y; Baco A; Mzembaba A; Cambau E; Vasconcellos SEG; Rigouts L; Suffys PN; Hasker E; Supply P; de Jong BC
Lancet Microbe; 2022 Sep; 3(9):e693-e700. PubMed ID: 35850123
[TBL] [Abstract][Full Text] [Related]
25. Severe type 1 upgrading leprosy reaction in a renal transplant recipient: a paradoxical manifestation associated with deficiency of antigen-specific regulatory T-cells?
Vieira AP; Trindade MAB; de Paula FJ; Sakai-Valente NY; Duarte AJDS; Lemos FBC; Benard G
BMC Infect Dis; 2017 Apr; 17(1):305. PubMed ID: 28438129
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of anti-bacterial activity of Rifapentine, Clarithromycin, Minocycline, Moxifloxacin, Ofloxacin and their combinations in Murine Model of Rifampicin Resistant Leprosy.
Joseph P; Ponnaiya J; Das M; Chaitanya VS; Arumugam S; Ebenezer M
Indian J Lepr; 2016; 88(3):147-58. PubMed ID: 30207440
[TBL] [Abstract][Full Text] [Related]
27. The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines.
Matsuoka M; Budiawan T; Aye KS; Kyaw K; Tan EV; Cruz ED; Gelber R; Saunderson P; Balagon V; Pannikar V
Lepr Rev; 2007 Dec; 78(4):343-52. PubMed ID: 18309708
[TBL] [Abstract][Full Text] [Related]
28. High frequency of ofloxacin resistance patterns of Mycobacterium leprae from India: An indication to revisit second line anti-leprosy treatment regimen.
Chhabra S; Narang T; Sahu S; Sharma K; Shilpa S; Sharma A; Jain S; Singh I; Yadav R; Kaur M; Sharma R; Nadeem M; Pandey P; Minz RW; Dogra S
J Glob Antimicrob Resist; 2023 Dec; 35():262-267. PubMed ID: 37852372
[TBL] [Abstract][Full Text] [Related]
29. Drug susceptibility of Mycobacterium leprae: a retrospective analysis of mouse footpad inoculation results from 1983 to 1997.
Sekar B; Elangeswaran N; Jayarama E; Rajendran M; Kumar SS; Vijayaraghavan R; Anandan D; Arunagiri K
Lepr Rev; 2002 Sep; 73(3):239-44. PubMed ID: 12449888
[TBL] [Abstract][Full Text] [Related]
30. [Multi-drug resistant Mycobacterium leprae from patients with leprosy].
Maeda S
Nihon Hansenbyo Gakkai Zasshi; 2004 Sep; 73(3):227-33. PubMed ID: 15508725
[TBL] [Abstract][Full Text] [Related]
31. Leprosy Drug Resistance Surveillance in Colombia: The Experience of a Sentinel Country.
Beltrán-Alzate C; López Díaz F; Romero-Montoya M; Sakamuri R; Li W; Kimura M; Brennan P; Cardona-Castro N
PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005041. PubMed ID: 27706165
[TBL] [Abstract][Full Text] [Related]
32. Multidrug therapy (MDT) and leprosy control.
Noordeen SK
Indian J Lepr; 1990; 62(4):448-58. PubMed ID: 2086680
[No Abstract] [Full Text] [Related]
33. Is drug-resistant Mycobacterium leprae a real cause for concern?: First approach to molecular monitoring of multibacillary Colombian patients with and without previous leprosy treatment.
Guerrero MI; Colorado CL; Torres JF; León CI
Biomedica; 2014 Apr; 34 Suppl 1():137-47. PubMed ID: 24968045
[TBL] [Abstract][Full Text] [Related]
34. [Comparative characterization of the antigenic composition of M. leprae and M. lufu].
Salamatina OS; Diachina MN; Iushchenko AA; Chernousova LN; Kalinina ON; Parshin MP
Probl Tuberk; 2001; (8):49-51. PubMed ID: 11767394
[TBL] [Abstract][Full Text] [Related]
35. An Overview of Treatment Guidelines and Methods of Synthesis of Drugs Used in Leprosy Chemotherapy.
Pinheiro LCS; Borges JC; Campos VR; Dantas LC
Mini Rev Med Chem; 2023; 23(4):497-512. PubMed ID: 35430972
[TBL] [Abstract][Full Text] [Related]
36. Drug resistance in leprosy: lessons from past and future perspective.
Gupta UD; Katoch VM
Indian J Lepr; 1999; 71(4):451-63. PubMed ID: 10804973
[TBL] [Abstract][Full Text] [Related]
37. Drug resistance in Mycobacterium leprae from patients with leprosy in China.
Liu D; Zhang Q; Sun Y; Wang C; Zhang Y; Fu X; Chen M; Zhou G; Yu X; Wang J; Liu H; Zhang F
Clin Exp Dermatol; 2015 Dec; 40(8):908-11. PubMed ID: 25991507
[TBL] [Abstract][Full Text] [Related]
38. Clinical pilot study: Clarithromycin efficacy in multibacillary leprosy therapy.
Gunawan H; Sasmojo M; Putri HE; Avriyanti E; Hindritiani R; Suwarsa O
Int J Mycobacteriol; 2018; 7(2):152-155. PubMed ID: 29900892
[TBL] [Abstract][Full Text] [Related]
39. DNA-PCR and RT-PCR for the 18-kDa gene of Mycobacterium leprae to assess the efficacy of multi-drug therapy for leprosy.
Chae GT; Kim MJ; Kang TJ; Lee SB; Shin HK; Kim JP; Ko YH; Kim SH; Kim NH
J Med Microbiol; 2002 May; 51(5):417-422. PubMed ID: 11990494
[TBL] [Abstract][Full Text] [Related]
40. Multidrug-resistance to dapsone, rifampicin, and ofloxacin in Mycobacterium leprae.
Cambau E; Perani E; Guillemin I; Jamet P; Ji B
Lancet; 1997 Jan; 349(9045):103-4. PubMed ID: 8996430
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
